TRENTON, N.J. - A New Jersey appellate court on March 25 said a trial court didn't err in excluding evidence that a plaintiff claimed would have proven that she developed osteonecrosis of the jaw (ONJ) after taking Fosamax (Alison Rosenberg, et al. v. Merck Sharp & Dohme, No. A-5271-10T3, N.J. Super., App. Div.; 2013 N.J. Super. Unpub. LEXIS 672; See 2/17/11, Page 4)....(read more)![]()
↧